According to a new market report published by Lucintel, the future of the exosome market looks promising with opportunities in academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories. The global exosome market is expected to grow with a CAGR of 24% from 2020 to 2025. The major drivers for this market are increasing funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome based procedures.
To download report brochure, please go to https://www.lucintel.com/exosome-market.aspx and click "download brochure" tab from the menu
Exosome are a type of extracellular vesicle that contain constituents, such as protein, DNA, and RNA, of the cells that secrete them. In this market, kits and reagents, instruments, and services are the major product & service segments. Lucintel forecasts that kits and reagents will remain the largest product & service segment over the forecast period due to the increasing demand for liquid biopsy tests, increasing basic research and commercial applications of exosome, and the need for reliable and specific diagnostic assays.
Within this market, academic & research institutes will remain the largest end user segment over the forecast period due to the growing use of exosome in cancer and stem cell research and increasing number of cancer & stem cell research projects across the globe.
North America will remain the largest region over the forecast period due to availability of government funding for life science research, favorable regulatory environment, increasing focus on exosome in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research.
Thermo Fisher Scientific, QIAGEN, Bio-Techne, System Biosciences, NX Pharmagen, Miltenyi Biotec, AMS Biotechnology, NanoSomiX, Lonza, and Norgen Biotek are among the major suppliers in the global exosome market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global exosome market by product and service, application, end user, workflow, bimolecule type, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Exosome Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global exosome market by product and service, application, end user, workflow, bimolecule type, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Kits and Reagents
Instruments
Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other Cancers
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Clinical Testing Laboratories
By Workflow [Value ($ Million) shipment analysis for 2014 – 2025]:
Ultracentrifugation
Immunocapture on Beads
Precipitation
Filtration
Cell Surface Marker Analysis Using Flow Cytometry
Protein Analysis Using Blotting & ELISA
RNA Analysis with NGS & PCR
Proteomic Analysis Using Mass Spectrometry
Others
By Biomolecule Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Non-Coding RNAs
mRNA
Proteins/Peptides
DNA Fragments
Lipids
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
Spain
Italy
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.